S

Senti Biosciences

119 employees

Senti Biosciences is a developer of a programmable biology platform for cancer therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Synthetic Biology
Health Care
Gene Therapy
Therapeutics
Medical
Cell Therapy

Date founded

2016

Funding rounds raised

Total raised

$105M

from 26 investors over 26 rounds

S

Senti Biosciences raised $51M on June 9, 2022

Investors: Parker Institute for Cancer Immunotherapy, T. Rowe Price, Leaps by Bayer, The Invus Group, Pear VC and 8VC

S

Senti Biosciences raised $5.2M on May 24, 2022

Investors: Leaps by Bayer

S

Senti Biosciences raised $1.9M on September 28, 2021

Investors: National Cancer Institute

S

Senti Biosciences raised undisclosed on May 14, 2021

Investors: Pear VC

S

Senti Biosciences raised $105M on January 6, 2021

Investors: Smilegate Investment, 经纬创投(北京)投资管理顾问有限公司, Ridgeback Capital Management LLC, Sand Hill Angels, Noveus Capital, Menlo Ventures and Pear VC

S

Senti Biosciences raised undisclosed on August 20, 2020

Investors: Bossa Nova Investimentos

S

Senti Biosciences raised undisclosed on January 16, 2019

Investors: Pear VC

S

Senti Biosciences raised $53M on February 27, 2018

Investors: Omega Funds, Evolution VC Partners, Lifeforce Capital, Lux Capital, Pear VC, Menlo Ventures and Allen & Company LLC.

S

Senti Biosciences raised undisclosed on September 22, 2016

Investors: Pear VC

FAQ